Teaching Diabetes Management Using Two Different Methods (Teaching)
30 de abril de 2026 actualizado por: Amasya University
The Effects of Teaching Diabetes Management to Nursing Students Using Two Different Methods on Knowledge Level, Critical Thinking, and Self-Efficacy
It is essential to evaluate teaching methods and include comprehensive teaching components for optimal educational outcomes.
Accordingly, this study will evaluate the effect of teaching diabetes management to nursing students using two different methods.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
Introduction and Aim: To provide effective diabetes education for nursing students, it is essential to evaluate teaching methods and include comprehensive teaching components for optimal educational outcomes. Accordingly, this study will evaluate the effect of teaching diabetes management to nursing students using two different methods.
Methods: The research will be conducted using a quasi-experimental research design with a pre-test/post-test control group. The sample will consist of students enrolled in the Internal Medicine Nursing course at a university nursing department. Data will be collected in two time periods: after theoretical information on diabetes and treatment/care practices is provided, and after jigsaw and case-based learning applications are completed. Students will be divided into three groups: jigsaw learning group, case-based learning group, and control group. Data will be collected using a Personal Information Form, Diabetes Knowledge Test, Critical Thinking Tendency Scale, and Self-Efficacy Scale.
Tipo de estudio
Intervencionista
Inscripción (Actual)
88
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Amasya, Turquía (Türkiye)
- AmasyaU
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Students enrolled in the Internal Medicine Nursing course during the 2023-2024 academic year,
- Students who attended the "diabetes management" theoretical course in Internal Medicine Nursing,
- Students who agreed to participate in the study.
Exclusion Criteria:
- Students who did not participate in the theoretical and jigsaw/case-based learning application phases of the study,
- Students who did not give their consent to participate in the study.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: jigsaw
Students in the jigsaw group will be divided into 5 groups of six.
Then, the topic content will be divided into five outlines (diabetes classification/symptoms and signs, diabetes treatment (nutrition and exercise), diabetes treatment (insulin and oral antidiabetics), acute and chronic complications of diabetes, patient education in diabetes), and each member of each jigsaw group will be assigned to a specific outline.
Students will be asked to study all the material by looking more closely at the given topic.
Then, all students assigned to the same outline in the 5 jigsaw groups will be gathered in a group called the "expert group."
In this expert group, each student will be asked to share and discuss the information they have gained regarding the specific outline with the other students.
|
Students in the jigsaw group will be divided into 5 groups of six.
Then, the topic content will be divided into five outlines (diabetes classification/symptoms and signs, diabetes treatment (nutrition and exercise), diabetes treatment (insulin and oral antidiabetics), acute and chronic complications of diabetes, patient education in diabetes), and each member of each jigsaw group will be assigned to a specific outline.
Students will be asked to study all the material by looking more closely at the given topic.
Then, all students assigned to the same outline in the 5 jigsaw groups will be gathered in a group called the "expert group."
In this expert group, each student will be asked to share and discuss the information they have gained regarding the specific outline with the other students.
|
|
Experimental: case based
The researcher will provide the students with 5 examples, and five case studies will be conducted with the students in the case-based learning group (cases will include information such as the patient's detailed history, medical diagnosis, a brief summary of the disease, and the medications the patient is using).
The case studies used will contain the basic details of diabetes.
Necessary background information will be provided, and discussion questions will be determined.
|
The researcher will provide the students with 5 examples, and five case studies will be conducted with the students in the case-based learning group (cases will include information such as the patient's detailed history, medical diagnosis, a brief summary of the disease, and the medications the patient is using).
The case studies used will contain the basic details of diabetes.
Necessary background information will be provided, and discussion questions will be determined.
|
|
Sin intervención: control
Control group: Students in the control group will not be given the simulation exercise; they will only fill out data collection forms during two designated time periods.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Diabetes Knowledge Test
Periodo de tiempo: 4 week
|
The knowledge test will consist of 20 questions on the physiology, signs, and treatment of septic shock.
The questions in the knowledge test will be sent to 5 experts for review, and content validity will be established.
|
4 week
|
|
Critical Thinking Tendency Scale
Periodo de tiempo: 4 week
|
The "Critical Thinking Tendency Scale" was developed in 2012 by Karalı and Battal to measure critical thinking tendencies.
The CTTS is a five-point Likert-type scale consisting of 21 items.
The scale has two sub-dimensions: "Skills Dimension" and "Values Dimension".
The Cronbach's alpha internal consistency reliability coefficient of the scale was found to be 0.91 (Karalı and Battal, 2012).
The highest possible score on the "Skills" subscale of the "Critical Thinking Tendency Scale" is 60, and the lowest is 12.
The highest possible score on the "Values" subscale is 45, and the lowest is 9.
The Cronbach's alpha internal consistency reliability coefficient of the scale was found to be 0.91.
|
4 week
|
|
Self-Efficacy Scale
Periodo de tiempo: 4 week
|
The scale is unidimensional and consists of 10 positive items, therefore it does not contain reverse-coded items.
Each item is given a score between 1 and 4, in equal intervals.
A higher score indicates higher self-efficacy.
The Cronbach's alpha internal consistency reliability coefficient of the scale adapted into Turkish and whose validity and reliability analyses were performed by Yurtçiçek Eren and Başgöl was found to be 0.81.
|
4 week
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
15 de octubre de 2025
Finalización primaria (Actual)
15 de diciembre de 2025
Finalización del estudio (Actual)
16 de enero de 2026
Fechas de registro del estudio
Enviado por primera vez
24 de abril de 2026
Primero enviado que cumplió con los criterios de control de calidad
30 de abril de 2026
Publicado por primera vez (Actual)
4 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
4 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
30 de abril de 2026
Última verificación
1 de abril de 2026
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- AU-689
- NU689 (Otro identificador: Amasya U)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .